Filing Details
- Accession Number:
- 0001209191-15-038091
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-01 17:42:17
- Reporting Period:
- 2015-04-29
- Filing Date:
- 2015-05-01
- Accepted Time:
- 2015-05-01 17:42:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1565985 | Russell Powers | 7475 Lusk Blvd. San Diego CA 92121 | Evp, International | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-04-29 | 9,471 | $45.40 | 73,482 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2015-05-01 | 4,016 | $26.62 | 77,498 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-05-01 | 2,410 | $44.44 | 75,088 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2015-05-01 | 4,016 | $0.00 | 4,016 | $26.62 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-01-03 | No | 4 | M | Direct |
Footnotes
- Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person on March 10, 2015, which is intended to comply with Rule 10b5-1.
- Weighted average from 2 transactions with prices of $45.000 and $46.620. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
- Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
- Sale of shares to cover the exercise price of the underlying stock option. Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person on March 10, 2015, which is intended to comply with Rule 10b5-1.
- Weighted average from 12 transactions with prices ranging from $44.3900 to $44.5000. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
- The option, representing a right to purchase a total of 2,234 shares, became exercisable as follows: 25% of the shares vested on January 3, 2012; the remaining shares vested monthly thereafter so that all shares were fully vested as of January 3, 2015, subject to continued employment through each vesting period.